Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Debt / NOTE 5.000% 4/0
-
Market price (% of par)
-
95.01%
-
Total 13F principal
-
$52,655,964
-
Principal change
-
+$52,655,964
-
Total reported market value
-
$51,513,000
-
Number of holders
-
7
-
Value change
-
+$51,513,000
-
Number of buys
-
7
Institutional Holders of AEGERION PHARMACEUTICALS INC - NOTE 5.000% 4/0 as of Q4 2019
As of 31 Dec 2019,
AEGERION PHARMACEUTICALS INC - NOTE 5.000% 4/0 was held by
7 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$52,655,964
in principal (par value) of the bond.
The largest 7 bondholders included
HIGHBRIDGE CAPITAL MANAGEMENT LLC, EdgePoint Investment Group Inc., AMERIPRISE FINANCIAL INC, Stonepine Capital Management, LLC, Whitebox Advisors LLC, Context Capital Management, LLC, and CITIGROUP INC.
This page lists
7
institutional bondholders reporting positions
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.